Moderna is reducing its workforce by approximately 10% globally, or 5,000 employees, by the end of the year. Earlier this year, the company announced plans to reduce its annual operating expenses by approximately $1.5 billion by 2027. The company has been scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs.  CEO Stephane Bancel, said, “Today, reshaping our operating structure and aligning our cost structure to the re...